Overview

  • Product name
    Naproxen sodium
  • Description
    Non-selective COX inhibitor
  • Biological description
    Non-selective COX inhibitor (IC50 values are 9.3 and 28 μM at COX-1 and COX-2, respectively). Analgesic, antipyretic and anti-inflammatory effects
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Levy D  et al. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci 27:917-22 (2008). Read more (PubMed: 18333963) »
  • Dhir A  et al. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur J Pharmacol 535:192-8 (2006). Read more (PubMed: 16522321) »
  • Warner TD  et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 96:7563-8 (1999). Read more (PubMed: 10377455) »
  • Sutton LB Naproxen sodium. J Am Pharm Assoc (Wash) NS36:663-7 (1996). Read more (PubMed: 8952254) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141033.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up